Subsets of Activated T Cells in Patients with Systemic Lupus Erythematosus: the Relation to Cell Cycle

References

• Jasin H E, Ziff M. Immunoglobulin synthesis by peripheral blood cells in systemic lupus erythematosus. Arthritis Rheum 1992; 18: 219–28
   Google Scholar
• Budman D R, Merchant E B, Steinberg A D, Doft B, Gershwin M E, Lizzio E, et al. Increased spontaneous activity of antibody-forming cells in the peripheral blood of patients with active SLE. Arthritis Rheum 1975; 20: 829–33
   Google Scholar
• Blaese R M, Grayson J, Steiberg AD. Increased immunoglob-ulin-secreting cells in the blood of patients with active systemic lupus erythematosus. Am J. Med 1980; 69: 345–50
   PubMed Web of Science ®Google Scholar
• Linker-Israeli M, Bakke A C, Kitridou R C, Gendler S, Gillis S, Horwitz DA. Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE). J. Immunol 1983; 130: 2651–5
   PubMed Web of Science ®Google Scholar
• Linker-Israeli M, Bakke A C, Quismorio FP, Jr, Horwitz DA. Correlation of interleukin-2 production in patients with systemic lupus erythematosus by removal of spontaneously activated suppressor cells. J Clin Invest 1985; 75: 762–8
   PubMed Web of Science ®Google Scholar
• Miyasaka N, Nakamura T, Russel I J, Talal N. Interleukin 2 deficiencies in rheumatoid arthritis and systemic lupus erythematosus. Clin Immunol Immunopathol 1984; 31: 109–17
   PubMedGoogle Scholar
• Murakawa Y, Takada S, Ueda Y, Suzuki N, Hoshino T, Sakane T. Characterization of T lymphocyte subpopulations responsible for deficient interleukin 2 activity in patients with systemic lupus erythematosus. J. Immunol 1985; 134: 187–94
   PubMed Web of Science ®Google Scholar
• Huang Y-P, Perrin L H, Miescher PA. Correlation of T and B cell activities in vitro and serum IL-2 levels in systemic lupus erythematosus. J. Immunol 1988; 141: 827–33
   PubMed Web of Science ®Google Scholar
• Klashman D J, Martin R A, Martinez-Maza O, Stevens RH. In vitro regulation of B cell differentiation by interleukin-6 and soluble CD23 in systemic lupus erythematosus B cell subpopulations and antigen-induced normal B cells. Arthritis Rheum 1991; 34: 276–86
   PubMed Web of Science ®Google Scholar
• Linker-Israeli M, Deans R J, Wallace D J, Prehn J, Ozeri-Chen T, Klinenberg J R. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. J Immunol 1991; 147: 117–23
   PubMed Web of Science ®Google Scholar
• Smolen J S, Chused T M, Leiserson W M, Reeves J P, Ailing D, Steinberg AD. Heterogeneity of immunoregulatory T-cell subsets in systemic lupus erythematosus. Am J Med 1982; 72: 783–90
   PubMed Web of Science ®Google Scholar
• Wolf R E, Brelsford WG. Soluble interleukin-2 receptors in systemic lupus erythematosus. Arthritis Rheum 1988; 31: 729–35
   PubMed Web of Science ®Google Scholar
• Tokano Y, Murashima A, Takasaki Y, Hashimoto H, Okumura K. Relation between soluble interleukin 2 receptor and clinical findings in patients with systemic lupus erythematosus. Ann Rheum Dis 1989; 48: 803–9
   PubMed Web of Science ®Google Scholar
• Yu D TY, Winchester R J, Fu S M, Gibofsky A, Ko H S, Kunkel HG. Peripheral blood la-positive T cells. Increases in certain diseases and after immunization. J Exp Med 1980; 151: 91–100
   PubMed Web of Science ®Google Scholar
• Hirano T, Taniguchi O, Koga K, Hashimoto H, Hirose S, Shiokawa Y, . The appearance of la+ T cell in systemic lupus erythematosus. Cellular, molecular and genetic approaches to immuno-diagnosis and immunotherapy, K Kano, S Mori, T Sugisaki, et al. University of Tokyo Press, Tokyo 1987; 441–5
   Google Scholar
• Tokano Y, Hishikawa T, Hirose T, Sekigawa I, Hashimoto H, Okumura K, et al. HLA-DP-positive T cells in patients with systemic lupus erythematosus. Autoimmunity 1990; 5: 179–83
   PubMed Web of Science ®Google Scholar
• Murashima A, Takasaki Y, Ohgaki M, Hashimoto H, Shirai T, Hirose S. Activated peripheral blood mononuclear cells detected by murine monoclonal antibodies to proliferating cell nuclear antigen in active lupus patients. J Clin Immunol 1990; 10: 28–37
   PubMed Web of Science ®Google Scholar
• Tan E M, Cohen A S, Fries J F, Masi A T, Mc Shane D J, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271–7
   PubMed Web of Science ®Google Scholar
• Liang W H, Socher S A, Larson M G, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989; 32: 1107–18
   PubMed Web of Science ®Google Scholar
• Bacon P A, Coppock J S, Isenberg D A, Maddison P H, Snaith M L, Symmons D PM, et al. A comparison of disease activity scores in SLE (abstract). Br J Rheumatol 1986; 15: 16A
   Google Scholar
• Lampson L A, Levy R. Two populations of la-like molecules on a human B cell line. J Immunol 1980; 125: 293–9
   PubMedGoogle Scholar
• Watson A J, De Mars R, Trowbridge I S, Bach FH. Detection of a novel human class II HLA antigen. Nature 1983; 304: 358–61
   PubMedGoogle Scholar
• Hishikawa T, Tokano Y, Sekigawa I, Ando S, Takasaki Y, Hashimoto H, et al. HLA-DP+ T cells and deficient interleukin-2 production in patients with systemic lupus erythematosus. Clin Immunol Immunopathol 1990; 55: 285–96
   PubMedGoogle Scholar
• Traganos F, Darzykiewicz Z, Sharpless T, Melamed MR. Simultaneous staining of ribonucleic and deoxyribonucleic acids in unfixed cells using acridine orange in a flow cytofluorometric system. J Histochem Cytochem 1977; 25: 46–56
   PubMed Web of Science ®Google Scholar
• Ueda G, Hirose S, Shirai T. An early activation antigen of murine T cells recognized by monoclonal natural autoantibody NTA204 and the expression on T cells from aged NZBXNZW Fl mice with overt autoimmune disease. Autoimmunity 1992; 12: 117–25
   PubMed Web of Science ®Google Scholar
• Pledger W J, Stiles C D, Antoniades H N, Scher CD. An ordered sequence of events is required before BALB/C-3T3 cells become committed to DNA synthesis. Proc Natl Acad Sci USA 1978; 75: 2839–43
   PubMed Web of Science ®Google Scholar
• Stiles C D, Capone G T, Scher C D, Antoniades H N, Van Wyk J J, Pledger WJ. Dual control of cell growth by somatomedins and platelet-derived growth factor. Proc Natl Acad Sci USA 1979; 78: 1279–83
   Google Scholar